Predictive Factors of Cardiac Function Recovery and Mortality in Patients with Reduced Ejection Fraction Undergoing Transcatheter Aortic Valve Implantation
- PMID: 40005384
- PMCID: PMC11857224
- DOI: 10.3390/medicina61020266
Predictive Factors of Cardiac Function Recovery and Mortality in Patients with Reduced Ejection Fraction Undergoing Transcatheter Aortic Valve Implantation
Abstract
Background and Objectives: Patients with reduced left ventricular ejection fraction (LVEF) are reported to have unfavorable outcomes following transcatheter aortic valve implantation (TAVI). This study aims to evaluate outcomes and identify predictive factors for LVEF recovery following TAVI in patients with reduced LVEF. Materials and Methods: This retrospective study analyzed 114 patients with symptomatic severe aortic stenosis (AS) with LVEF < 40% who underwent TAVI between 2011 and 2023 at two centers. Echocardiographic parameters, including LVEF, ventricular dimensions, and relative wall thickness (RWT), were assessed at baseline and during follow-up. The outcomes and predictors of substantial LVEF improvement and mortality were analyzed using univariate and multivariate logistic regression methods. Results: Anemia (OR = 4.345, 95% CI: 1.208-15.626, p = 0.024), RWT (OR = 1.224, 95% CI: 1.064-1.407, p = 0.005), and early post-procedural changes in left ventricular end-systolic dimension (LVESD) (OR = 1.297, 95% CI: 1.037-1.622, p = 0.023) and left ventricular end-diastolic dimension (LVEDD) (OR = 1.346, 95% CI: 1.034-1.753, p = 0.027) at one-month follow-up were identified as significant factors associated with LVEF recovery at one year. Regarding factors related to mortality, higher baseline AVMG levels were associated with a lower probability of death after one year (OR = 0.926, 95% CI: 0.875-0.979, p = 0.007). Conversely, a more limited increase in LVEF from baseline to the final follow-up was linked to poor prognosis and higher mortality at one year (95% CI: 1.045-1.594, p = 0.018). Conclusions: This study demonstrated that TAVI in patients with AS and reduced LVEF can be performed with high procedural success, low mortality, and significant improvement in cardiac function during follow-up. Additionally, anemia, baseline RWT, and early post-procedural changes in LVESD and LVEDD were identified as factors associated with LVEF recovery. Baseline AVMG and changes in LVEF at the final follow-up were found to be significant predictors of total mortality.
Keywords: aortic stenosis; heart failure; reduced ejection fraction; transcatheter aortic valve implantation.
Conflict of interest statement
The authors declare no conflicts of interest related to this study.
Figures

Similar articles
-
Sustained favourable haemodynamics 1 year after TAVI: improvement in NYHA functional class related to improvement of left ventricular diastolic function.Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1269-1278. doi: 10.1093/ehjci/jev306. Epub 2015 Nov 20. Eur Heart J Cardiovasc Imaging. 2016. PMID: 26588980
-
Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction.Circulation. 2010 Nov 9;122(19):1928-36. doi: 10.1161/CIRCULATIONAHA.109.929893. Epub 2010 Oct 25. Circulation. 2010. PMID: 20975002
-
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction.Am J Cardiol. 2017 Nov 1;120(9):1639-1647. doi: 10.1016/j.amjcard.2017.07.064. Epub 2017 Aug 1. Am J Cardiol. 2017. PMID: 28844511
-
Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.JAMA Cardiol. 2019 Jan 1;4(1):64-70. doi: 10.1001/jamacardio.2018.4320. JAMA Cardiol. 2019. PMID: 30566185 Free PMC article. Clinical Trial.
-
Impact of the recovery of left ventricular ejection fraction after TAVI on mortality in patients with aortic stenosis.Turk Kardiyol Dern Ars. 2021 Dec;49(8):606-614. doi: 10.5543/tkda.2021.66495. Turk Kardiyol Dern Ars. 2021. PMID: 34881698
References
-
- Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation. 2002;106:3006–3008. doi: 10.1161/01.CIR.0000047200.36165.B8. - DOI - PubMed
-
- El-Chilali K., Patsalis P.C., Al-Rashid F., Kahlert H.A., Riebisch M., Mincu R.I., Totzeck M., Lind A., Jánosi R.A., Kehren C., et al. Impact of baseline left ventricular ejection fraction on outcome after transfemoral transcatheter aortic valve implantation in patients with and without low-gradient aortic stenosis. Echocardiography. 2019;36:28–37. doi: 10.1111/echo.14203. - DOI - PubMed
-
- Clavel M.A., Webb J.G., Rodés-Cabau J., Masson J.B., Dumont E., De Larochellière R., Doyle D., Bergeron S., Baumgartner H., Burwash I.G., et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122:1928–1936. doi: 10.1161/CIRCULATIONAHA.109.929893. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials